Lab Week 2026 | From Innovation to Impact

Join us for an engaging and informative webinar exploring the latest advances in clinical flow cytometry and how these innovations are shaping the future of diagnostics and research.

Finding the Last Cell Standing: Flow Cytometry in Myeloma Diagnosis and MRD

Paul K. Wallace, SciGro, Inc., Sedona, AZ; International Society for Advancement of Cytometry, Washington, DC  

Multiple myeloma (MM) is a heterogeneous group of mature B cell diseases that are typically characterized by the presence and accumulation of abnormal plasma cells (PCs), which results in the excess production of monoclonal immunoglobulin and/or light chain found in the serum and/or urine. Multiparametric flow cytometry (MFC) is an indispensable tool to supplement the diagnosis, classification, and monitoring of the disease due to its high patient applicability, excellent sensitivity, and encouraging results from various clinical trials. In this regard, minimal or, more appropriately, measurable residual disease (MRD) negativity by MFC has been recognized as a powerful predictor of favorable long-term outcomes. We will examine how flow cytometry can be effectively implemented in the clinical setting for both the diagnosis and measurement of MM MRD. The current consensus guidelines for flow cytometric processing of samples and reporting of results for MM MRD testing will be reviewed. Finally, we also discuss alternative approaches to detect plasma cells using blood samples. 

Optimizing a Multiple Myeloma Flow Cytometry Assay in the Context of Anti-CD38 Therapy

Jessica Hughes, Staff Scientist, Hematopathology

Flow cytometry can be a powerful tool in the diagnosis and monitoring of plasma cell neoplasms. This webinar covers pre-analytical, analytical, and post-analytical considerations for optimizing plasma cell recovery, instrument settings, classification of normal vs abnormal, and special considerations for patients receiving CD38-directed therapy. 

CellMek in Action

Sandra Hernandez & Antoine Pacheco

Witness a laboratory session with Antoine Pacheco, Platform Manager for Clinical Instrumentation, as he will use the CellMek SPS instrument for automated sample preparation. Discover the instrument's unique features that can simplify your laboratory workflow.  

These discussions will shed light on how these novel tools can improve accuracy, speed, and overall efficiency in the laboratory, and shape the future of clinical flow cytometry.

Learn & Earn! We’re also offering two P.A.C.E ™ credits to attendees, further enriching their professional development.

Don't miss this unique opportunity to gain valuable insights, explore the latest advancements in laboratory diagnostics, and discover strategies for optimizing your laboratory workflows.

Beckman Coulter Life Sciences is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. 

For more information, please visit www.ascls.org/pace